Variation in the calpain-10 gene is associated with elevated triglyceride levels and reduced adipose tissue messenger ribonucleic acid expression in obese swedish subjects

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 7, 2004, Pages 3601-3605

  Carlsson, Emma ^a   Fredriksson, Jenny ^a   Groop, Leif ^a   Ridderstråle, Martin ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

RNA; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CALPAIN 10 GENE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENDER; GENE; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 3242728272     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-032105     Document Type: Article

References (34)

1. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, Hinokio Y, Lindner TH, Mashima H, Schwartz PE, del Bosque-Plata L, Horikawa Y, Oda Y, Yoshiuchi I, Colilla S, Polonsky KS, Wei S, Concannon P, Iwasaki N, Schulze J, Baier LJ, Bogardus C, Groop L, Boerwinkle E, Hanis CL, Bell GI 2000 Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 26:163-175
2. Baier LJ, Permana PA, Yang X, Pratley RE, Hanson RL, Shen G-Q, Mott D, Knowler WC, Cox NJ, Horikawa Y, Oda N, Bell GI, Bogardus C 2001 A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J Clin Invest 106:R69-R73
3. Screenan SK, Zhou Y-P, Otani K, Hansen PA, Currie KPM, Pan C-Y, Lee J-P, Ostrega DM, Pugh W, Horikawa Y, Cox NJ, Hanis CL, Burant CF, Fox AP, Bell GI, Polonsky KS 2001 Calpains play a role in insulin secretion and action. Diabetes 50:2013-2020
4. Molinari M, Carafoli E 1997 Calpain: a cytosolic proteinase active at the membranes. J Membr Biol 156:1-8
5. Paul DS, Harmon AW, Winston CP, Patel YM 2003 Calpain facilitates GLUT4 vesicle translocation during insulin-stimulated glucose uptake in adipocytes. Biochem J 15:625-632
6. Zhou Y-P, Sreenan S, Pan C-Y, Currie KPM, Bindokas VP, Horikawa Y, Lee J-P, Osrega D, Ahmed N, Baldwin AC, Cox NJ, Fox AP, Miller RJ, Bell GI, Polonsky KS 2003 A 48-hour exposure of pancreatic islets to calpain inhibitors impairs mitochondrial fuel metabolism and the exocytosis of insulin. Metabolism 5:528-534
7. Groop L, Forsblom C, Lehtovirta M, Tuomi T, Karanko S, Nissen M, Ehrnström BO, Forsen B, Isomaa B, Snickars B, Taskinen MR 1996 Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects. Diabetes 45:1585-1593
8. Beck-Nielsen H, Groop L 1994 Metabolic and genetic characterization of prediabetic states: sequence of events leading to non-insulin-dependent diabetes mellitus. J Clin Invest 94:1714-1721
9. Groop L, Orho-Melander M 2001 The dysmetabolic syndrome. J Intern Med 250:105-120
10. Boden G 1997 Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46:3-10
11. Jacob S, Machann J, Rett K, Brechtel K, Volk A, Renn W, Maerker E, Matthaei S, Schick F, Claussen CD, Haring HU 1999 Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes 48:1113-1119
12. Perseghin G, Scifo P, De Cobelli F, Pagliato E, Battezzati A, Arcelloni C, Vanzulli A, Testolin G, Pozza G, Del Maschio A, Luzi L 1999 Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans. Diabetes 48:1600-1606
13. Orho-Melander M, Klannemark M, Svensson M, Ridderstråle M, Lindgren C, Groop L 2002 Variants in the calpain-10 gene predispose to insulin resistance and elevated free fatty acid levels. Diabetes 51:2658-2664
14. 3-adrenoceptor function in human fat cells. J Clin Endocrinol Metab 87:3362-3367
15. Daimon M, Oizumi T, Saitoh T, Kameda W, Yamaguchi H, Ohnuma H, Igarashi M, Manaka H, Kato T 2002 Calpain 10 gene polymorphisms are related, not to type 2 diabetes, but to increased serum cholesterol in Japanese. Diabetes Res Clin Pract 56:147-152
16. Vandenplas S, Wiid I, Grobler-Rabie A, Brebner K, Ricketts M, Wallis G, Bester A, Boyd C, Mathew C 1984 Blot hybridisation analysis of genomic DNA. J Med Genet 21:164-172
17. Yang X, Pratley RE, Baier LJ, Horikawa Y, Bell GI, Bogardus C, Permana PA 2001 Reduced skeletal muscle calpain-10 transcript level is due to cumulative decrease in major isoforms. Mol Genet Metab 73:111-113
18. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES 1996 Parametric and non-parametric linkage analysis: a unified multipoint approach. Am J Hum Genet 58:1347-1363
19. Stumvoll M, Fritsche A, Madaus A, Stefan N, Weisser M, Machicao F, Haring H 2001 Functional significance of the UCSNP-43 polymorphism in the CAPN10 gene for proinsulin processing and insulin secretion in nondiabetic Germans. Diabetes 50:2161-2163
20. Tsai HJ, Sun G, Weeks DE, Kaushal R, Wolujewicz M, McGarvey ST, Tufa J, Viali S, Deka R 2001 Type 2 diabetes and three calpain-10 gene polymorphisms in Samoans: no evidence of association. Am J Hum Genet 69:1236-1244
21. Garant MJ, Kao WHL, Brancati F, Coresh J, Rami TM, Hanis CL, Boerwinkle E, Shuldiner AR 2002 SNP43 of CAPN10 and the risk of type 2 diabetes in African-Americans. Diabetes 51:231-237
22. Hoffstedt J, Ryden M, Löfgren P, Orho-Melander M, Groop L, Arner P 2002 Polymorphism in the calpain 10 gene influences glucose metabolism in human fat cells. Diabetologia 45:276-282
23. Fingerlin TE, Erdos MR, Watanabe RM, Wiles KR, Stringham HM, Mohlke KL, Silander K, Valle TT, Buchanan TA, Tuomilehto J, Bergman RN, Boehnke M, Collins FS 2002 Variation in three single nucleotide polymorphisms in the calpain-10 gene not associated with type 2 diabetes in a large Finnish cohort. Diabetes 51:1644-1648
24. Malecki MT, Moczulski DK, Klupa T, Wanic K, Cyganek K, Frey J, Sieradzki J 2002 Homozygous combination of calpain 10 gene haplotype is associated with type 2 diabetes mellitus in a Polish population. Eur J Endocrinol 146:695-699
25. Shore AC, Evans JC, Frayling TM, Clark PM, Lee BC, Horikawa Y, Hattersley AT, Tooke JE 2002 Association of the calpain-10 gene with microvascular function. Diabetologia 45:899-904
26. Lynn S, Evans JC, White C, Frayling TM, Hattersley AT, Turnbull DM, Horikawa Y, Cox NJ, Bell GI, Walker M 2002 Variation in the calpain-10 gene affects blood glucose levels in the British population. Diabetes 51:247-250
27. Rasmussen SK, Urhammer SA, Berglund L, Jensen JN, Hansen L, Echwald SM, Borch-Johnsen K, Horikawa Y, Mashima H, Lethell H, Cox NJ, Hansen T, Mell GI, Pedersen O 2002 Variants within the calpain-10 gene on chromosome 2q37 (NIDDM1) and relationships to type 2 diabetes, insulin resistance, and impaired acute insulin secretion among Scandinavian Caucasians. Diabetes 51:3561-3567
28. Hinnley A, Antwerpen B, Geller F, Schäfer H, Siegfried W, Goldschmidt H, Remschmidt H, Ziegel A, Hebebrand J 2002 No evidence for involvement of the calpain-10 gene "high-risk" haplotype combination for non-insulin-dependent diabetes mellitus in early onset diabetes. Mol Genet Metab 76:152-156
29. Evans JC, Frayling TM, Cassell PG, Saker PJ, Hitman GA, Walker M, Levy JC, O'Rahilly S, Subba Rao PV, Bennett AJ, Jones EC, Menzel S, Prestwich P, Simecek N, Wishart M, Dhillon R, Fletcher C, Millward A, Demaine A, Wilkin T, Horikawa Y, Cox NJ, Bell GI, Ellard S, McCarthy MI, Hattersley A 2001 Studies of association between the gene for calpain-10 and type 2 diabetes in the United Kingdom. Am J Hum Genet 69:544-552
30. Cassell P, Jackson AE, North BV, Evans JC, Syndercombe-Court D, Phillips C, Ramachandran A, Snehalatha C, Gelding SV, Vijayaravaghan S, Curtis D, Hitman GA 2002 Haplotype combinations of calpain 10 gene polymorphisms associate with increase risk of impaired glucose tolerance and type 2 diabetes in South Indians. Diabetes 51:1622-1628
31. Stumvoll M, Wahl HG, Machicao WF, Häring H 2002 Insulin sensitivity of glucose disposal and lipolysis: no influence of common genetic variants in IRS-1 and CAPN10. Diabetologia 45:651-656
32. 1c levels in Japanese. Clin Chim Acta 336:89-96
33. Yan H, Yuan W, Velculescu VE, Vogelstein B, Kinzler KW 2002 Allelic variation in human gene expression. Science 297:1143
34. Arner P 1997 Regional adipocity in man. J Endocrinol 155:191-192